Centene reaffirmed full-year 2026 GAAP diluted EPS guidance above $3.11 and adjusted diluted EPS guidance above $4.80. The benchmarks set the Earnings measures management will discuss with investors during the Deutsche Bank 2026 Healthcare Summit and subsequent meetings through the week of September 21.
Key Highlights
- Management discussions with investors will continue through the week of September 21.
- The 2026 guidance remains effective through September 25 unless Centene publicly updates or reaffirms it.
- Centene’s full-year 2026 GAAP diluted EPS guidance is greater than $3.11, and adjusted diluted EPS guidance is greater than $4.80.
CENTENE CORP (NYSE: CNC) said management will discuss reaffirming full-year 2026 GAAP Diluted Earnings per Share guidance above $3.11 and adjusted diluted EPS guidance above $4.80.
$3.11 GAAP and $4.80 Adjusted EPS Guidance
The company said it uses non-GAAP measures internally to evaluate performance, plan operations and determine employee incentive compensation. A reconciliation between GAAP diluted EPS and adjusted diluted EPS is available in a press release dated July 28.
Guidance Remains Effective Through September 25
The guidance applies through September 25 and will not be updated or reaffirmed unless Centene publicly announces updated or affirmed guidance. Centene described the 2026 outlook as forward-looking and cautioned that actual results may differ because of economic, regulatory, competitive and other factors. Management discussions with investors continue through the week of September 21, while a live audio webcast will accompany the healthcare summit and a replay will be available afterward through Centene’s investor website.
FAQs
Q: What is Centene’s 2026 adjusted EPS guidance?
A: Centene’s full-year 2026 adjusted diluted EPS guidance is greater than $4.80. The filing says management will discuss reaffirming this guidance during the conference and in subsequent discussions with investors.
Q: What is Centene’s 2026 GAAP EPS guidance?
A: Centene’s full-year 2026 GAAP diluted EPS guidance is greater than $3.11. The filing says management will discuss reaffirming this guidance during the conference and in subsequent discussions with investors.
Q: How long is Centene’s 2026 guidance effective?
A: The guidance is effective through September 25. Centene said it will not update or reaffirm the outlook unless it publicly announces updated or affirmed guidance.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.